AbbVie, announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie.
"Together with ImmunoGen,...
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or...
Reveal Technology, Inc. proudly announces the acquisition of DFL Technology. With this acquisition, Reveal Technology's existing hardware-agnostic 3D modeling analytics software will now have...
Veracyte, Inc., a leading cancer diagnostics company, announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities...
RTI Surgical, an industry leading contract development and manufacturing organization (CDMO), serving the regenerative medicine industry, announced that it has completed its previously announced...
